Outcomes and toxicity from a prospective study of moderately hypofractionated radiation therapy for prostate cancer.

Adv Radiat Oncol · 2018 · PMC6000067 · PMID 29904741

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

13 Another trial from MD Anderson randomized 203 patients treated with IMRT to 75.6 Gy in 42 fractions versus 72 Gy in 30 fractions and found a nonsignificant trend toward inferior GI toxicity in the hypofractionated arm. 14 In addition, Fox Chase conducted a trial enrolling 303 patients and IMRT planning, randomizing patients between 76 Gy in 36 fractions versus 70.2 Gy in 26 fractions.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.